Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference22 articles.
1. Carmona L, Cross M, Williams B, Lassere M et al (2010) Rheumatoid arthritis. Best Pract Res Clin Rheumatol 24(6):733–745.
https://doi.org/10.1016/j.berh.2010.10.001
2. Burmester GR, Pope JE (2017) Novel treatment strategies in rheumatoid arthritis. Lancet 389(10086):2338–2348.
https://doi.org/10.1016/S0140-6736(17)31491-5
3. Smolen JS, Landewe R, Bijlsma J, Burmester G et al (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960–977.
https://doi.org/10.1136/annrheumdis-2016-210715
4. Gonzalez-Alvaro I, Descalzo MA, Carmona L, Estudio de la Morbilidad y Expresion Clinica de la Artritis Reumatoide Study G (2008) Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort. Arthritis Res Ther 10(6):R138.
https://doi.org/10.1186/ar2561
5. Toledano E, Ortiz AM, Ivorra-Cortes J, Montes N et al (2017) Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study. Clin Exp Rheumatol 36:382–388
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献